Last reviewed · How we verify
NCT06603207: RAPD-MR
Study of the Causal Link Between Rheumatoid Arthritis and Periodontitis Using Mendelian Randomization
trial in Rheumatoid Arthritis in 220,000 participants. Not yet recruiting.
1 November 2024
Quick facts
| Lead sponsor | Zhibin Xu |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 220,000 |
| Start date | 1 October 2024 |
| Primary completion | 1 November 2024 |
| Estimated completion | 1 December 2024 |
Conditions studied
- Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
- Periodontitis — all drugs for Periodontitis →
Sponsor
Zhibin Xu — full company profile →
Who can join
Eligibility, any sex, with Rheumatoid Arthritis or Periodontitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to investigate the causal relationship between rheumatoid arthritis and periodontitis using Mendelian randomization. Data will be sourced from genome-wide association studies (GWAS) to explore genetic associations and assess potential risk factors in an East Asian population.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Causal association between rheumatoid arthritis and periodontitis: A Mendelian randomization study
Li X, Ouyang Y, Liang L, Li Y. · · 2026
Verify or expand the search:
- PubMed search for NCT06603207
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rheumatoid Arthritis
Currently open trials in the same condition.
- NCT07433335 — A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07491016 — Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis · recruiting
- NCT07171983 — A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
- NCT07363590 — A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) · Phase 1 · recruiting
Other Zhibin Xu trials
Trials by the same sponsor.
- NCT06668974 — Causal Associations Between Allergic Rhinitis and Asthma · completed
- NCT06613750 — Comparative Study of Sitagliptin and Gliclazide With Metformin in Type 2 Diabetes Patients With Glucotoxicity · Phase 4 · completed
- NCT06594133 — Longitudinal and Cross-sectional Analysis of Pulmonary Microbiota in Lung Transplant Recipients Infected With Nocardia · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06603207 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zhibin Xu
- Last refreshed: 20 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06603207.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing